Sana Biotechnology SANA

$ 2.62 11.28%

Quarterly report 2024-Q3
added 11-08-2024

Sana Biotechnology Balance Sheet 2011-2024 | SANA

Annual Balance Sheet Sana Biotechnology

	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
Net Debt	-29.4 M	-68.5 M	-142 M	-	-31.8 M	-30.6 M	-	-	-	-	-	-	-
Long Term Debt	90.9 M	95.9 M	102 M	-	-	-	-	-	-	-	-	-	-
Long Term Debt Current	13.2 M	12.4 M	9.16 M	-	-	-	-	-	-	-	-	-	-
Total Non Current Liabilities	-	-	-	-	538 M	45.7 M	-	-	-	-	-	-	-
Total Current Liabilities	64.5 M	112 M	99.2 M	-	-	-	-	-	-	-	-	-	-
Total Liabilities	278 M	323 M	401 M	1.15 B	558 M	47.5 M	-	-	-	-	-	-	-
Deferred Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-
Retained Earnings	-1.34 B	-1.05 B	-785 M	-429 M	-144 M	-13.2 M	-	-	-	-	-	-	-
Total Assets	565 M	823 M	1.13 B	730 M	416 M	34.3 M	-	-	-	-	-	-	-
Cash and Cash Equivalents	134 M	177 M	253 M	125 M	-	-	-	-	-	-	-	-	-
Book Value	288 M	499 M	729 M	-421 M	-143 M	-13.2 M	-	-	-	-	-	-	-
Total Shareholders Equity	288 M	499 M	729 M	-421 M	-	-	-	-	-	-	-	-	-

All numbers in USD currency

Quarterly Balance Sheet Sana Biotechnology

	2024-Q3	2024-Q2	2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
Long Term Debt	85.5 M	88.6 M	92.9 M	90.9 M	83.4 M	100 M	102 M	95.9 M	99.9 M	-	103 M	102 M	92.4 M	66.1 M	66.3 M	68.2 M	68.2 M	68.2 M	68.2 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Non Current Liabilities	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Liabilities	267 M	279 M	306 M	278 M	266 M	352 M	319 M	323 M	332 M	-	346 M	401 M	403 M	354 M	422 M	299 M	299 M	299 M	299 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Deferred Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Retained Earnings	-1.56 B	-1.5 B	-1.45 B	-1.34 B	-1.25 B	-1.25 B	-1.14 B	-1.05 B	-974 M	-	-817 M	-785 M	-675 M	-591 M	-610 M	-429 M	-429 M	-429 M	-429 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Assets	559 M	619 M	681 M	565 M	631 M	707 M	747 M	823 M	898 M	-	1.05 B	1.13 B	1.23 B	1.26 B	1.3 B	730 M	730 M	730 M	730 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Cash and Cash Equivalents	127 M	135 M	177 M	134 M	172 M	184 M	171 M	177 M	174 M	205 M	197 M	253 M	442 M	675 M	751 M	125 M	125 M	125 M	125 M	81.8 M	-	-	-	31.4 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Book Value	292 M	340 M	375 M	288 M	366 M	355 M	428 M	499 M	566 M	-	702 M	729 M	830 M	906 M	882 M	432 M	432 M	432 M	432 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Shareholders Equity	292 M	340 M	375 M	288 M	366 M	355 M	428 M	499 M	566 M	640 M	702 M	729 M	830 M	906 M	882 M	-421 M	-421 M	-421 M	-421 M	-143 M	-	-	-	-13.2 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency